Literature DB >> 22917709

Use of personalized decision analysis in decision making for Palliative vs. surgical management of the oldest-old patients with localized skin cancer in a culturally sensitive environment: a case study of a 96-year-old male Taiwanese patient.

Chun-Ru Chien1, Ya-Chen Tina Shih.   

Abstract

Clinical management of older cancer patients is challenging, especially for those in the oldest-old age group. In the Chinese culture, the preference toward noninvasive care for patients in this age group may create a difficult situation for clinicians when the cancer is potentially curable. Palliative care may not always be the obvious choice, especially if patients suffer from quality-of-life impairment because of symptoms related to progression of the untreated cancer. Balancing between higher rates of toxicities and potential gains in quality of life from anticancer therapies among the oldest old presents a real challenge in clinical practice. Decision analysis is an analytical tool that has a long history of successful application in clinical decision making. In this case study of a 96-year-old male with localized skin cancer, we demonstrate that personalized decision analysis can be a helpful tool to assist decision making in the clinical management of cancer patients in the oldest-old age group, especially in situations in which the evidence-based literature provides little guidance. This was achieved by providing information to help the key decision makers to better understand the risk-benefit trade offs and make an informed decision. We found that the option of surgical management was associated with higher expected quality-adjusted life years (0.894) than best supportive care (0.853). Based on this finding and various scenarios explored in sensitivity analyses, the family members recommended surgery for the patient. The patient recovered well from surgery and there is no evidence of recurrence to date.
Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22917709     DOI: 10.1016/j.jpainsymman.2012.03.004

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  6 in total

1.  Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysis.

Authors:  Te-Chun Hsia; Chih-Yen Tu; Hsin-Yuan Fang; Ji-An Liang; Chia-Chin Li; Chun-Ru Chien
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Optimal interval of surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: population level evidence in addition to controlled trial.

Authors:  William Tzu-Liang Chen; Tao-Wei Ke; Yu-Min Liao; Chia-Chin Li; Chun-Ru Chien
Journal:  J Gastrointest Oncol       Date:  2015-06

3.  Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: a population-based analysis.

Authors:  Hsin-Yuan Fang; Fei-Yuan Hsiao; Hsu-Chih Huang; Yu-Sen Lin; Chih-Yi Chen; Shwn-Huey Shieh; Pin-Ru Chen; Chein-Kuang Chen; Chun-Ru Chien
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

4.  Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West.

Authors:  William Tzu-Liang Chen; Tao-Wei Ke; Chia-Chin Li; Chun-Ru Chien
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-24       Impact factor: 4.553

5.  Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis.

Authors:  Chun-Ru Chien; Te-Chun Hsia; Chih-Yi Chen
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

6.  Successful tongue cancer surgery under general anesthesia in a 99-year-old patient in Okinawa, Japan: A case report and review of the literature.

Authors:  Tessho Maruyama; Toshiyuki Nakasone; Akira Matayoshi; Akira Arasaki
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.